{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:29:56Z","timestamp":1787588996035,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,17]]},"DOI":"10.7759\/cureus.21326","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T15:44:20Z","timestamp":1642434260000},"source":"Crossref","is-referenced-by-count":3,"title":["Physicians\u2019 Practice of the Non-Cosmetic Uses of Botulinum Toxin: A Cross-Sectional Study in Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Sarah  A","family":"Alzarah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda","family":"Alabasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujain","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munirah","family":"Aldawsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etedal","family":"Aldawsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2016.04.024","article-title":"The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions - An evidence based review","volume":"25","author":"Awan KH","year":"2017","unstructured":"Awan KH. The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions - An evidence based review. Saudi Pharm J. 2017, 25:18-24. 10.1016\/j.jsps.2016.04.024","journal-title":"Saudi Pharm J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/11624.5341","article-title":"BOTOX: broadening the horizon of dentistry","volume":"8","author":"Nayyar P","year":"2014","unstructured":"Nayyar P, Kumar P, Nayyar PV, Singh A. BOTOX: broadening the horizon of dentistry. J Clin Diagn Res. 2014, 8:ZE25-9. 10.7860\/JCDR\/2014\/11624.5341","journal-title":"J Clin Diagn Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/ciia.2007.2.1.81","article-title":"Cosmetic use of botulinum toxin type A in the elderly","volume":"2","author":"Cheng CM","year":"2007","unstructured":"Cheng CM. Cosmetic use of botulinum toxin type A in the elderly. Clin Interv Aging. 2007, 2:81-3. 10.2147\/ciia.2007.2.1.81","journal-title":"Clin Interv Aging"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.05.033","article-title":"A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasm","volume":"367","author":"Fezza J","year":"2016","unstructured":"Fezza J, Burns J, Woodward J, Truong D, Hedges T, Verma A. A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasm. J Neurol Sci. 2016, 367:56-62. 10.1016\/j.jns.2016.05.033","journal-title":"J Neurol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1044\/1092-4388(2002\/037)","article-title":"Botox treatment in adductor spasmodic dysphonia: a meta-analysis","volume":"45","author":"Boutsen F","year":"2002","unstructured":"Boutsen F, Cannito MP, Taylor M, Bender B. Botox treatment in adductor spasmodic dysphonia: a meta-analysis. J Speech Lang Hear Res. 2002, 45:469-481. 10.1044\/1092-4388(2002\/037)","journal-title":"J Speech Lang Hear Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial","volume":"30","author":"Aurora SK","year":"2010","unstructured":"Aurora SK, Dodick DW, Turkel CC, et al.. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010, 30:793-803. 10.1177\/0333102410364676","journal-title":"Cephalalgia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2008.06.031","article-title":"A comparison of the effects of botulinum toxin A and steroid injection on nasal allergy","volume":"139","author":"Yang TY","year":"2008","unstructured":"Yang TY, Jung YG, Kim YH, Jang TY. A comparison of the effects of botulinum toxin A and steroid injection on nasal allergy. Otolaryngol Head Neck Surg. 2008, 139:367-71. 10.1016\/j.otohns.2008.06.031","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0495.1000225","article-title":"Therapeutic uses of botulinum toxin","volume":"5","author":"Gooriah R","year":"2014","unstructured":"Gooriah R, Ahmed F. Therapeutic uses of botulinum toxin.  J Clin Toxicol. 2014, 5:1. 10.4172\/2161-0495.1000225","journal-title":"J Clin Toxicol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10070299","article-title":"Botulinum toxin for the treatment of hand tremor","volume":"10","author":"Niemann N","year":"2018","unstructured":"Niemann N, Jankovic J. Botulinum toxin for the treatment of hand tremor. Toxins (Basel). 2018, 10:299. 10.3390\/toxins10070299","journal-title":"Toxins (Basel)"},{"key":"ref10","article-title":"Intradetrusor onabotulinumtoxinA injection: how I do it","volume":"20","author":"Shenot PJ","year":"2013","unstructured":"Shenot PJ, Mark JR. Intradetrusor onabotulinumtoxinA injection: how I do it. Can J Urol. 2013, 20:6649-55.","journal-title":"Can J Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.aanat.2011.09.002","article-title":"The two main theories on dental bruxism","volume":"194","author":"Behr M","year":"2012","unstructured":"Behr M, Hahnel S, Faltermeier A, B\u00fcrgers R, Kolbeck C, Handel G, Proff P. The two main theories on dental bruxism. Ann Anat. 2012, 194:216-9. 10.1016\/j.aanat.2011.09.002","journal-title":"Ann Anat"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.11138\/FNeur\/2013.28.4.253","article-title":"Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey","volume":"28","author":"Smania N","year":"2013","unstructured":"Smania N, Colosimo C, Bentivoglio AR, Sandrini G, Picelli A. Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey. Funct Neurol. 2013, 28:253-8. 10.11138\/FNeur\/2013.28.4.253","journal-title":"Funct Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-61724-4_9","article-title":"Non-cosmetic botulinum toxin treatments in the head and neck","author":"Madden LL RC","year":"2018","unstructured":"Madden LL RC. Non-cosmetic botulinum toxin treatments in the head and neck. Neurolaryngology. Sittel C, Guntinas-Lichius O (ed): Springer, Cham, Switzerland; 2018. 109-23. 10.1007\/978-3-319-61724-4_9"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(06)00590-8","article-title":"Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics","volume":"176","author":"Schmid DM","year":"2006","unstructured":"Schmid DM, Sauermann P, Werner M, et al.. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol. 2006, 176:177-85. 10.1016\/S0022-5347(06)00590-8","journal-title":"J Urol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2000.0149","article-title":"Treating severe bruxism with botulinum toxin","volume":"131","author":"Tan EK","year":"2000","unstructured":"Tan EK, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc. 2000, 131:211-6. 10.14219\/jada.archive.2000.0149","journal-title":"J Am Dent Assoc"},{"key":"ref16","unstructured":"Botox AHM. (2016). https.\/\/www.activehealth.com\/content\/2018\/10\/botox-ahm-2.pdf."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e318296e630","article-title":"Dysport (botulinum toxin type A) in routine therapeutic usage. A telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes","volume":"36","author":"Hubble J","year":"2013","unstructured":"Hubble J, Schwab J, Hubert C, Abbott CC. Dysport (botulinum toxin type A) in routine therapeutic usage. A telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes. Clin Neuropharmacol. 2013, 36:122-7. 10.1097\/WNF.0b013e318296e630","journal-title":"Clin Neuropharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1159\/000370245","article-title":"Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin","volume":"95","author":"Yiannakopoulou E","year":"2015","unstructured":"Yiannakopoulou E. Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin. Pharmacology. 2015, 95:65-9. 10.1159\/000370245","journal-title":"Pharmacology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology, pharmacology, and toxicology","volume":"69","author":"Pirazzini M","year":"2017","unstructured":"Pirazzini M, Rossetto O, Eleopra R, Montecucco C. Botulinum neurotoxins: biology, pharmacology, and toxicology. Pharmacol Rev. 2017, 69:200-35. 10.1124\/pr.116.012658","journal-title":"Pharmacol Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.570671","article-title":"Botulinum Neurotoxin-A injection in adult cervical dystonia and spastic paresis: results from the INPUT (INjection Practice, Usage and Training) survey","volume":"11","author":"Chung TM","year":"2020","unstructured":"Chung TM, Jacinto LJ, Colosimo C, Bhatia KP, Tiley J, Bhidayasiri R. Botulinum Neurotoxin-A injection in adult cervical dystonia and spastic paresis: results from the INPUT (INjection Practice, Usage and Training) survey. Front Neurol. 2020, 11:570671. 10.3389\/fneur.2020.570671","journal-title":"Front Neurol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.11138\/fneur\/2017.32.2.103","article-title":"Ixcellence Network\u00ae: an international educational network to improve current practice in the management of cervical dystonia or spastic paresis by botulinum toxin injection","volume":"32","author":"Fheodoroff K","year":"2017","unstructured":"Fheodoroff K, Bhidayasiri R, Jacinto LJ, Chung TM, Bhatia K, Landreau T, Colosimo C. Ixcellence Network\u00ae: an international educational network to improve current practice in the management of cervical dystonia or spastic paresis by botulinum toxin injection. Funct Neurol. 2017, 32:103-10. 10.11138\/fneur\/2017.32.2.103","journal-title":"Funct Neurol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2019.784","article-title":"Botulin toxin use in rosacea and facial flushing treatment","volume":"7","author":"Scala J","year":"2019","unstructured":"Scala J, Vojvodic A, Vojvodic P, et al.. Botulin toxin use in rosacea and facial flushing treatment. Open Access Maced J Med Sci. 2019, 7:2985-7. 10.3889\/oamjms.2019.784","journal-title":"Open Access Maced J Med Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.11138\/fneur\/2018.33.1.037","article-title":"Management of spasticity with onabotulinumtoxinA: practical guidance based on the Italian real-life post-stroke spasticity survey","volume":"33","author":"Sandrini G","year":"2018","unstructured":"Sandrini G, Baricich A, Cisari C, Paolucci S, Smania N, Picelli A. Management of spasticity with onabotulinumtoxinA: practical guidance based on the Italian real-life post-stroke spasticity survey. Funct Neurol. 2018, 33:37-43. 10.11138\/fneur\/2018.33.1.037","journal-title":"Funct Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/toxins9110375","article-title":"Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: an observational study","volume":"9","author":"Picelli A","year":"2017","unstructured":"Picelli A, Baricich A, Chemello E, et al.. Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: an observational study. Toxins (Basel). 2017, 9:375. 10.3390\/toxins9110375","journal-title":"Toxins (Basel)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.11138\/fneur\/2017.32.2.089","article-title":"The Italian real-life post-stroke spasticity survey: unmet needs in the management of spasticity with botulinum toxin type A","volume":"32","author":"Picelli A","year":"2017","unstructured":"Picelli A, Baricich A, Cisari C, Paolucci S, Smania N, Sandrini G. The Italian real-life post-stroke spasticity survey: unmet needs in the management of spasticity with botulinum toxin type A. Funct Neurol. 2017, 32:89-96. 10.11138\/fneur\/2017.32.2.089","journal-title":"Funct Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13060374","article-title":"Early botulinum toxin type A injection for post-stroke spasticity: a longitudinal cohort study","volume":"13","author":"Picelli A","year":"2021","unstructured":"Picelli A, Santamato A, Cosma M, et al.. Early botulinum toxin type A injection for post-stroke spasticity: a longitudinal cohort study. Toxins (Basel). 2021, 13:374. 10.3390\/toxins13060374","journal-title":"Toxins (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-0976-1","article-title":"An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study","volume":"20","author":"Ahmed F","year":"2019","unstructured":"Ahmed F, Gaul C, Garc\u00eda-Monc\u00f3 JC, Sommer K, Martelletti P. An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study. J Headache Pain. 2019, 20:26. 10.1186\/s10194-019-0976-1","journal-title":"J Headache Pain"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/2150132720959936","article-title":"Patient-reported outcomes from a 1-year, real-world, head-to-head comparison of onabotulinumtoxinA and topiramate for headache prevention in adults with chronic migraine","volume":"11","author":"Blumenfeld AM","year":"2020","unstructured":"Blumenfeld AM, Patel AT, Turner IM, Mullin KB, Manack Adams A, Rothrock JF. Patient-reported outcomes from a 1-year, real-world, head-to-head comparison of onabotulinumtoxinA and topiramate for headache prevention in adults with chronic migraine. J Prim Care Community Health. 2020, 11:2150132720959936. 10.1177\/2150132720959936","journal-title":"J Prim Care Community Health"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-021-00253-0","article-title":"Early management of onabotulinumtoxina treatment in chronic migraine: insights from a real-life European multicenter study","volume":"10","author":"Ornello R","year":"2021","unstructured":"Ornello R, Ahmed F, Negro A, et al.. Early management of onabotulinumtoxina treatment in chronic migraine: insights from a real-life European multicenter study. Pain Ther. 2021, 10:637-50. 10.1007\/s40122-021-00253-0","journal-title":"Pain Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01113-6","article-title":"Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data","volume":"21","author":"Ornello R","year":"2020","unstructured":"Ornello R, Guerzoni S, Baraldi C, et al.. Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data. J Headache Pain. 2020, 21:40. 10.1186\/s10194-020-01113-6","journal-title":"J Headache Pain"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/83491-physicians-practice-of-the-non-cosmetic-uses-of-botulinum-toxin-a-cross-sectional-study-in-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:31Z","timestamp":1707507691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/83491-physicians-practice-of-the-non-cosmetic-uses-of-botulinum-toxin-a-cross-sectional-study-in-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.21326","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,17]]}}}